Affiliation:
1. Allergy Center, Casa di Cura Villa Montallegro, 16145 Genoa, Italy
2. Department of Otolaryngology, University of Molise, 86100 Campobasso, Italy
Abstract
Respiratory tract infections (RTIs) are usually characterized by mucus hypersecretion. This condition may worsen and prolong symptoms and signs. For this reason, reducing mucus production and improving mucus removal represent relevant aspects of managing patients with RTIs. In this regard, mucoactive drugs may be effective. Mucoactive agents constitute a large class of compounds characterized by different mechanisms of action. Sobrerol is a monoterpene able to fluidify mucus, increase mucociliary clearance, and exert antioxidant activity. Sobrerol is available in various formulations (granules, syrup, nebulized, and suppository). Sobrerol has been on the market for over 50 years. Therefore, the present article revised the evidence concerning this compound and proposed new possible strategies. The literature analysis showed that several studies investigated the efficacy and safety of sobrerol in acute and chronic RTIs characterized by mucus hyperproduction. Seven pediatric studies have been conducted with favorable outcomes. However, the regulatory agencies recently reduced the treatment duration to three days. Therefore, a future study will test the hypothesis that a combination of oral and topical sobrerol could benefit children and adults with frequent respiratory tract infections. The rationale of this new approach is based on the concept that mucus accumulation could be a risk factor for increased susceptibility to infections.
Subject
Pediatrics, Perinatology and Child Health
Reference90 articles.
1. What are the most common conditions in primary care? Systematic review;Finley;Can. Fam. Physician,2018
2. Upper Respiratory Tract Infection-Associated Acute Cough and the Urge to Cough: New Insights for Clinical Practice;Murgia;Pediatr. Allergy Immunol. Pulmonol.,2020
3. Esneau, C., Duff, A.C., and Bartlett, N.W. (2022). Understanding Rhinovirus Circulation and Impact on Illness. Viruses, 14.
4. Coronavirus infections and immune responses;Li;J. Med. Virol.,2020
5. Influenza Virus;Hutchinson;Trends Microbiol.,2018